Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sandow

Showing results (181-190 of 189) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 189 results.
Iscience|July 8, 2022
Ubiquitylation of RIPK3 beyond-the-RHIM can limit RIPK3 activity and cell deathDaniel Frank, Sarah E Garnish, Jarrod J Sandow, et al.
Cancer Discovery|May 15, 2021
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell MemoryEmily J Lelliott, Isabella Y Kong, Magnus Zethoven, et al.
Cold Spring Harbor Perspectives in Biology|July 19, 2017
Role of the β Common (βc) Family of Cytokines in Health and DiseaseTimothy R Hercus, Winnie L T Kan, Sophie E Broughton, et al.
Nature Communications|March 18, 2015
A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine productionUeli Nachbur, Che A Stafford, Aleksandra Bankovacki, et al.
Nature Communications|November 28, 2018
VDAC2 enables BAX to mediate apoptosis and limit tumor developmentHui San Chin, Mark X Li, Iris K L Tan, et al.
Cell|May 18, 2021
The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancerStephin J Vervoort, Sarah A Welsh, Jennifer R Devlin, et al.
Nature Chemical Biology|October 9, 2019
A small molecule interacts with VDAC2 to block mouse BAK-driven apoptosisMark F van Delft, Stephane Chappaz, Yelena Khakham, et al.
Science (New York, N.Y.)|December 21, 2019
A class of γδ T cell receptors recognize the underside of the antigen-presenting molecule MR1Jérôme Le Nours, Nicholas A Gherardin, Sri H Ramarathinam, et al.
Molecular Cell|May 21, 2021
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibitionSimon J Hogg, Olga Motorna, Leonie A Cluse, et al.
Pageof 19

Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Iscience|July 8, 2022
Ubiquitylation of RIPK3 beyond-the-RHIM can limit RIPK3 activity and cell deathDaniel Frank, Sarah E Garnish, Jarrod J Sandow, et al.
Cancer Discovery|May 15, 2021
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell MemoryEmily J Lelliott, Isabella Y Kong, Magnus Zethoven, et al.
Cold Spring Harbor Perspectives in Biology|July 19, 2017
Role of the β Common (βc) Family of Cytokines in Health and DiseaseTimothy R Hercus, Winnie L T Kan, Sophie E Broughton, et al.
Nature Communications|March 18, 2015
A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine productionUeli Nachbur, Che A Stafford, Aleksandra Bankovacki, et al.
Nature Communications|November 28, 2018
VDAC2 enables BAX to mediate apoptosis and limit tumor developmentHui San Chin, Mark X Li, Iris K L Tan, et al.
Cell|May 18, 2021
The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancerStephin J Vervoort, Sarah A Welsh, Jennifer R Devlin, et al.
Nature Chemical Biology|October 9, 2019
A small molecule interacts with VDAC2 to block mouse BAK-driven apoptosisMark F van Delft, Stephane Chappaz, Yelena Khakham, et al.
Science (New York, N.Y.)|December 21, 2019
A class of γδ T cell receptors recognize the underside of the antigen-presenting molecule MR1Jérôme Le Nours, Nicholas A Gherardin, Sri H Ramarathinam, et al.
Molecular Cell|May 21, 2021
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibitionSimon J Hogg, Olga Motorna, Leonie A Cluse, et al.
Pageof 19